"MART-1 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells.
| Descriptor ID |
D058965
|
| MeSH Number(s) |
D12.776.624.301.750 D23.050.285.439.750
|
| Concept/Terms |
MART-1 Antigen- MART-1 Antigen
- Antigen, MART-1
- MART 1 Antigen
- MART1 Antigens
- Antigens, MART1
- MelanA
- Melanoma Antigen Recognized by T-Cells 1
- Melanoma Antigen Recognized by T Cells 1
- MART1 Antigen
- Antigen, MART1
- Melan-A
- Melan A
|
Below are MeSH descriptors whose meaning is more general than "MART-1 Antigen".
Below are MeSH descriptors whose meaning is more specific than "MART-1 Antigen".
This graph shows the total number of publications written about "MART-1 Antigen" by people in this website by year, and whether "MART-1 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2016 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "MART-1 Antigen" by people in Profiles.
-
Ellison PM, Zitelli JA, Brodland DG. Mohs micrographic surgery for melanoma: A prospective multicenter study. J Am Acad Dermatol. 2019 Sep; 81(3):767-774.
-
Valent?n-Nogueras SM, Brodland DG, Zitelli JA, Gonz?lez-Sep?lveda L, Nazario CM. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ. Dermatol Surg. 2016 Jun; 42(6):733-44.
-
Terushkin V, Brodland DG, Sharon DJ, Zitelli JA. Digit-Sparing Mohs Surgery for Melanoma. Dermatol Surg. 2016 Jan; 42(1):83-93.
-
Thompson JM, Bermudez-Magner JA, Barker NH, Payne D, Meghpara B, Dubovy SR. Balloon cell nevi of the conjunctiva: Clinicopathologic correlation and literature review. Surv Ophthalmol. 2015 Sep-Oct; 60(5):481-5.
-
Shields JA, Eagle RC, Dutton J, Ehya H, Shields CL. Adenocarcinoma of the retinal pigment epithelium: clinicopathologic correlation with paradoxical immunohistochemical findings. JAMA Ophthalmol. 2014 Oct; 132(10):1249-52.
-
Bardliving CL, Lowe AJ, Huang CJ, Manley L, Ritter G, Old L, Batt CA. Process development and production of cGMP grade Melan-A for cancer vaccine clinical trials. Protein Expr Purif. 2013 Dec; 92(2):171-82.
-
Faure F, Mantegazza A, Sadaka C, Sedlik C, Jotereau F, Amigorena S. Long-lasting cross-presentation of tumor antigen in human DC. Eur J Immunol. 2009 Feb; 39(2):380-90.
-
Li J, Mookerjee B, Wagner J. Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy. J Immunother. 2008 Jan; 31(1):81-8.
-
Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch Dermatol. 2006 Jul; 142(7):871-6.